173 related articles for article (PubMed ID: 6293978)
1. Ceftriaxone: in vitro activity against 410 bacterial isolates compared with cefotaxime.
Digranes A; Benonisen E; Dibb WL
Infection; 1982; 10(5):307-9. PubMed ID: 6293978
[TBL] [Abstract][Full Text] [Related]
2. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF
Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
[TBL] [Abstract][Full Text] [Related]
3. Ceftriaxone: a summary of in vitro antibacterial qualities including recommendations for susceptibility tests with 30-micrograms disks.
Jones RN; Barry AL; Thornsberry C
Diagn Microbiol Infect Dis; 1983 Dec; 1(4):295-311. PubMed ID: 6321093
[TBL] [Abstract][Full Text] [Related]
4. [In vitro activity of ceftriaxone on hospital bacteria. Results of a multicenter study].
Soussy CJ; Deforges L; Le Van Thoi J; Chanal M; Sirot D; Acar JF; Kitzis MD; Thabaut A; Meyran M; Dabernat H
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):469-72. PubMed ID: 2868442
[TBL] [Abstract][Full Text] [Related]
5. The in vitro activity of moxalactam against 430 clinical, bacterial isolates.
Digranes A; Benonisen E; Dibb WL; Ostervold B
Acta Pathol Microbiol Immunol Scand B; 1982 Feb; 90(1):69-72. PubMed ID: 6211028
[TBL] [Abstract][Full Text] [Related]
6. Comparative in-vitro activity and mode of action of ceftriaxone (Ro 13-9904), a new highly potent cephalosporin.
Hall MJ; Westmacott D; Wong-Kai-In P
J Antimicrob Chemother; 1981 Sep; 8(3):193-203. PubMed ID: 6270051
[No Abstract] [Full Text] [Related]
7. The in vitro antibacterial activity of ceftriaxone in comparison with nine other antibiotics.
Emmerson AM; Lamport PA; Reeves DS; Bywater MJ; Holt HA; Wise R; Andrews J; Hall MJ
Curr Med Res Opin; 1985; 9(7):480-93. PubMed ID: 3928265
[TBL] [Abstract][Full Text] [Related]
8. Cefotaxime: a review of in vitro antimicrobial properties and spectrum of activity.
Jones RN; Thornsberry C
Rev Infect Dis; 1982; 4 Suppl():S300-15. PubMed ID: 6294779
[TBL] [Abstract][Full Text] [Related]
9. N-formimidoyl thienamycin: in vitro comparison with cefoxitin and tobramycin against clinical, bacterial isolates.
Digranes A; Dibb WL; Benonisen E
Acta Pathol Microbiol Immunol Scand B; 1983 Apr; 91(2):141-4. PubMed ID: 6603093
[TBL] [Abstract][Full Text] [Related]
10. Third-generation and investigational cephalosporins: II. Microbiologic review and clinical summaries.
Garzone P; Lyon J; Yu VL
Drug Intell Clin Pharm; 1983 Sep; 17(9):615-22. PubMed ID: 6311502
[TBL] [Abstract][Full Text] [Related]
11. [Sensitivity to cefotiam of 494 hospital bacterial strains. Determination of minimal inhibitory concentration and comparison with other beta-lactams].
Reynaud A; Desnoes M; Derriennic M; Courtieu AL
Pathol Biol (Paris); 1985 May; 33(5):313-9. PubMed ID: 3929216
[TBL] [Abstract][Full Text] [Related]
12. Clavulanic acid in combination with ticarcillin: an in-vitro comparison with other beta-lactams.
Clarke AM; Zemcov SJ
J Antimicrob Chemother; 1984 Feb; 13(2):121-8. PubMed ID: 6323375
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of Ro 13-9904, a new beta-lactamase-stable cephalosporin.
Verbist L; Verhaegen J
Antimicrob Agents Chemother; 1981 Feb; 19(2):222-5. PubMed ID: 6289726
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of the new 4-quinolone compound Ro 23-6240.
Clarke AM; Zemcov SJ
Eur J Clin Microbiol; 1987 Apr; 6(2):161-4. PubMed ID: 3109895
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic and microbial susceptibility studies of ceftriaxone.
Baumgartner JD; Glauser MP
Eur J Clin Microbiol; 1983 Oct; 2(5):501-4. PubMed ID: 6315426
[TBL] [Abstract][Full Text] [Related]
16. [In vitro antibacterial activity of cefmenoxime (SCE 1365)].
Brun Y; Forey F; Coulet M; Fleurette J; Bryskier A
Pathol Biol (Paris); 1983 May; 31(5):343-6. PubMed ID: 6312394
[TBL] [Abstract][Full Text] [Related]
17. Antibacterial activity in vitro and regression studies for ceftazidime and ceftriaxone.
Frimodt-Møller N; Højbjerg T; Hvass E; Møller S; Mortensen I; Thomsen VF
Acta Pathol Microbiol Immunol Scand B; 1985 Jun; 93(3):181-8. PubMed ID: 3929558
[TBL] [Abstract][Full Text] [Related]
18. [Multicenter study of the in vitro effect of imipenem (N-formimidoyl-thienamycin) on hospital bacteria].
Soussy CJ; Otterbein G; Le Van Thoi J; Thabaut A; Meyran M; Courtieu AL; Reynaud A; Dabernat H; Lareng MB; Chanal M
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):487-92. PubMed ID: 3911142
[TBL] [Abstract][Full Text] [Related]
19. Comparative in vitro activity of three new quinolone antibiotics against recent clinical isolates.
Forsgren A
Scand J Infect Dis; 1985; 17(1):91-4. PubMed ID: 3158070
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of ceftazidime and ceftriaxone.
Keenholtz SL; Jacobus NV; Tally FP; Gorbach SL
Clin Ther; 1983; 5(6):603-16. PubMed ID: 6313195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]